About Celestis Pharmaceuticals Private Limited
Data last updated:
Celestis Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Abhaya Investment Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 23 June 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2014PTC079868. Its GSTIN is 24AAFCC6904M1ZJ (Gujarat).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹13.81 Lakh. It is led by directors including Mousumi Jayanta Mandal and Sunita Pravin Thombare.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/2 Sbi Super Society Ramdevnagar Satellite, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.3 Lakh, a decline of 31% compared to the previous year. For the same year it recorded a net loss of ₹16.84 Lakh (net margin -392.1%) and EBITDA of -₹13.6 Lakh (EBITDA margin -316.6%). Revenue has declined at a compounded annual rate (CAGR) of 41% over three years and 40% over five years.
The company is associated with 1 brand: Celestis Pharmaceuticals. The company has 1 deal on record (1 funding round), with disclosed funding of ₹1.15 Cr; the latest was in January 2016.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website celestispharma.com.
Company details
Contact details
Celestis Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is celestispharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC/2 Sbi Super Society Ramdevnagar Satellite, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Celestis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Celestis Pharmaceuticals operates one associated brand: Celestis Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Research and development in Active Pharmaceutical Ingredients, intermediates, and impurities are conducted in India. | celestispharma.com |
Business activity
The main business activity of Celestis Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Celestis Pharmaceuticals Private Limited, buy the company report.
Financials of Celestis Pharmaceuticals Private Limited
FY 2025 filings availableCelestis Pharmaceuticals Private Limited reported revenue of ₹4.3 Lakh (down 31% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 40% over five years, including a 31% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹13.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹16.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -316.6% | ||||
| Net Profit Margin | -392.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Celestis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Celestis Pharmaceuticals Private Limited
Celestis Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mousumi Jayanta Mandal Also directs: JSM Innovations LLP, Apdm Pharmaceuticals Private Limited | Director | 23 Jun 2014 | 12 Years 4 Months | Current |
| Sunita Pravin Thombare | Director | 23 Jun 2014 | 12 Years 4 Months | Current |
| Pravin Sahadev Thombare | Director | 23 Jun 2014 | 12 Years 4 Months | Current |
Auditor
Celestis Pharmaceuticals Private Limited is audited by K S DAS & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K S DAS & ASSOCIATES | FY 2019 | 135157W |
Shareholding
The shareholding of Celestis Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Celestis Pharmaceuticals Private Limited, buy the company report.
Deals & funding
Celestis Pharmaceuticals Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹1.15 Cr; the latest was in January 2016.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2016 | Funding round | ₹1.15 Cr |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Celestis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Celestis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Celestis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCC6904M1ZJ | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Celestis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Celestis Pharmaceuticals Private Limited has 5 board changes on record since 2014: 3 appointments and 2 cessations. The latest: Jayanta Kumar Mandal ceased to be Director on 01 Mar 2023.
Frequently asked questions
Celestis Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 23 June 2014 (12+ years old) and is registered under CIN U24100GJ2014PTC079868.
Celestis Pharmaceuticals has 3 current directors:
- Mousumi Jayanta Mandal - Director
- Sunita Pravin Thombare - Director
- Pravin Sahadev Thombare - Director
The latest financial statements of Celestis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Celestis Pharmaceuticals is 24AAFCC6904M1ZJ, registered in Gujarat.
The CIN (Corporate Identification Number) of Celestis Pharmaceuticals is U24100GJ2014PTC079868. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Celestis Pharmaceuticals was incorporated on 23 June 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Celestis Pharmaceuticals has 1 deal on record (1 funding round), with disclosed funding of ₹1.15 Cr; the latest was in January 2016.
Jayanta Kumar Mandal ceased to be Director on 01 Mar 2023. Pravin Sahadev Thombare ceased to be Ceo(Kmp) on 31 Mar 2022. Mousumi Jayanta Mandal was appointed as Director on 23 Jun 2014. Celestis Pharmaceuticals has 5 board changes on record in total.
Celestis Pharmaceuticals can be reached through the website celestispharma.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Celestis Pharmaceuticals is at C2 Sbi Super Society Ramdevnagar Satellite, Ahmedabad, Gujarat, India – 380015.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
